These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 17177680

  • 1. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils.
    von Bredow C, Hartl D, Schmid K, Schabaz F, Brack E, Reinhardt D, Griese M.
    Clin Exp Allergy; 2006 Dec; 36(12):1566-74. PubMed ID: 17177680
    [Abstract] [Full Text] [Related]

  • 2. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 3. Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
    Mahajan L, Madan T, Kamal N, Singh VK, Sim RB, Telang SD, Ramchand CN, Waters P, Kishore U, Sarma PU.
    Int Immunol; 2008 Aug; 20(8):993-1007. PubMed ID: 18628238
    [Abstract] [Full Text] [Related]

  • 4. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [Abstract] [Full Text] [Related]

  • 5. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx.
    Vieira-de-Abreu A, Amendoeira FC, Gomes GS, Zanon C, Chedier LM, Figueiredo MR, Kaplan MA, Frutuoso VS, Castro-Faria-Neto HC, Weller PF, Bandeira-Melo C, Bozza PT.
    Int Immunopharmacol; 2005 Dec; 5(13-14):1966-74. PubMed ID: 16275631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms.
    Jäkel A, Clark H, Reid KB, Sim RB.
    Immunobiology; 2010 Jul; 215(7):551-8. PubMed ID: 19880212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surfactant protein D in human lung diseases.
    Hartl D, Griese M.
    Eur J Clin Invest; 2006 Jun; 36(6):423-35. PubMed ID: 16684127
    [Abstract] [Full Text] [Related]

  • 15. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
    Kobayashi M, Takeuchi T, Ohtsuki Y.
    Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
    Costa GG, Silva RM, Franco-Penteado CF, Antunes E, Ferreira HH.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):200-5. PubMed ID: 17368616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.
    Saito Y, Takeda M, Nishikawa J, Konno Y, Tamaki M, Itoga M, Kobayashi Y, Moritoki Y, Ito W, Chihara J, Ueki S.
    Pulm Pharmacol Ther; 2014 Apr 02; 27(2):164-9. PubMed ID: 24333185
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.